The Celtic Advanced Life Science Innovation Network (CALIN), is a € 11.96 million, 4-year, Ireland-Wales funded programme that will bring innovation, jobs and growth to Ireland and Wales. Joining forces: Bangor, Cardiff and Swansea Universities in Wales, and University College Dublin, The National University of Ireland, Galway and the Tyndall Institute, University College Cork in Ireland, bring together expertise, access to emerging technologies and routes to market that will support businesses in the regions to bring new life science products to market.
As well as open access to the six universities, the CALIN network includes the global healthcare leaders Unilever and GE Healthcare. Activities within CALIN are focused on three themes: Precision Medicine (diagnostics, devices & therapeutics), Regenerative Medicine and Bio-Compatibility & Safety Evaluation, and each CALIN business will be linked to two universities, providing access to all the tools required for innovation and growth. CALIN also provides access to a unique network of supply chain companies and knowledge transfer opportunities that will enhance business growth.
The research, development and technological support offered to Welsh and Irish businesses through CALIN, will develop the international competitiveness of both regions. It will also set the stage for longer term relationships between business and academia in Wales, Ireland and beyond.